Global Vaccines Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2016 and Forecast 2017 to 2024

Global Vaccines Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2016 and Forecast 2017 to 2024

Global Vaccine Market to Worth US $ XX Bn by 2025 , Due to to the Rising Prevalence of Diseases

“The Global Vaccine Market is anticipated to reach about US$ XX Bn by 2025, and anticipated to expand at a CAGR over seven years of forecast period 2019-2025” owing to an increasing prevalence of diseases amongst the population.

Precision Business Insights (PBI) in its report titled “Global Vaccine Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global vaccine market size was accounted for US$ XX Bn in 2018 and anticipated to account for US$ XX Bn by 2025. The growth of the market is attributed to the rising prevalence of diseases, increasing government and nongovernment funding for vaccine development, and increasing companies initiatives to enhance R&D. However, the high cost associated with development of new vaccines contributes to the main factor for restraining the growth of vaccine market.

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-vaccines-market/#ulp-h4n2eZVGqb32xpPc

Global vaccine market segmented on the basis of technology, disease indication, geography.

Conjugate Segment Expected to Dominate the Market

Based on technology type, the global vaccine market is segmented as conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, and toxoid vaccines. In 2018, the conjugate segment is expected to account for the largest share of the market. The growth in this market is mainly driven by increasing investments by the government of developing countries and rising prevalence of infectious diseases.

Meningococcal Segment Will Hold the Major Revenue Share.

By disease indication, the market is segmented into pneumococcal disease, influenza, DTP, hepatitis, human papillomavirus (HPV), rotavirus, meningococcal disease, MMR (measles, mumps, and rubella), varicella, polio, herpes zoster, dengue, and other disease indications. The meningococcal segment is expected to register the highest rate during the forecast period. The growth in this segment can primarily be attributed to the increasing government investments in meningococcal vaccination programs and high prevalence of meningococcal disease.

North America Accounts for Major Revenue Share for Vaccine Market

Precision Business Insights (PBI) global vaccine market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America is expected to dominate the market. The large share of this geographical segment is attributed to factors such as increasing investments by government organizations and companies to promote immunization as well as develop new vaccines. Europe is expected to hold the second largest share of this market. Factors such as availability of funding and venture capital investments for the development of new vaccines and increasing government initiatives are expected to drive market growth in this region.

New Product Launch and US FDA Approval Play a Vital Role in Global Vaccine Market

The increased R&D investment from pharmaceutical companies, research organizations and biotech companies are expected to create demand for vaccine market. For instance, GlaxoSmithKline has the official go-ahead for its next big launch, the FDA approved the company's new shingles vaccine, Shingrix.
Key player’s profiles in the report are Astellas Pharma Inc., Astrazeneca Plc. (Medimmune, LLC.), CSL Limited, Emergent Biosolutions, Inc., Glaxosmithkline Plc., Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Sanofi Pasteur, Serum Institute of India Pvt. Ltd., Gritstone Oncology, PaxVax Corporation., Bavarian Nordic, Bharat Biotech., VBI Vaccines Inc., Novavax, Inc., Dynavax Technologies Corporation, Immunomic Therapeutics, Inc., Gamma Vaccines Pty Limited, Sinovac Biotech Ltd., Prokarium, and ImmunoBiology Ltd.
Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-vaccines-market/#ulp-c654SbFYO64MsOhu

Detailed Segmentation

By Technology Type

o Conjugate Vaccines
o Inactivated Vaccines
o Live Attenuated Vaccines
o Toxoid Vaccines
o Recombinant Vaccines
o Other Vaccines

By Indication Type

o Pneumococcal Disease
o Influenza
o Human Papilloma Virus
o Meningococcal Disease
o Rotavirus
o Varicella
o Diphtheria, Pertussis, and Tetanus (DPT)
o Polio
o Hepatitis
o Measles, Mumps, and Rubella (MMR)
o Other Indications

By End-User Type

o Pediatric Vaccines
o Adult Vaccines
o Traveler Vaccines

Geography

o North America
 U.S.
 Canada
o Europe
 Germany
 UK
 France
 Russia
 Spain
 Italy
 Rest of Europe
o Asia-Pacific
 China
 Japan
 India
 ASEAN
 Rest of Asia Pacific
o Latin America
 Brazil
 Mexico
 Argentina
 Chile
 Rest of Latin America
o Middle East and Africa
 South Africa
 Saudi Arabia
 Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-vaccines-market/

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553
Website @ www.precisionbusinessinsights.com

This release was published on openPR.